Journal article icon

Journal article

Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study.

Abstract:

Introduction

Seasonal (inactivated) influenza vaccination is recommended for all individuals aged 65+ and in individuals under 65 who are at an increased risk of complications of influenza infection, for example, people with asthma. Live attenuated influenza vaccine (LAIV) was recommended for children as they are thought to be responsible for much of the transmission of influenza to the populations at risk of serious complications from influenza. A phased roll-out of the LAIV pil...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Role:
Author
ORCID:
0000-0002-5194-8083
More from this funder
Name:
Asthma UK
Grant:
AUK-AC-2012-01
More from this funder
Name:
Chief Scientist Office of the Scottish Government
Grant:
AUK-AC-2012-01
More from this funder
Name:
Medical Research Council
Grant:
MC_PC_13040
More from this funder
Name:
National Institute for Health Research
Grant:
13/34/14
Publisher:
BMJ Publishing Group
Journal:
BMJ Open More from this journal
Volume:
7
Issue:
2
Pages:
e014200
Publication date:
2017-02-01
Acceptance date:
2017-01-12
DOI:
EISSN:
2044-6055
ISSN:
2044-6055
Pmid:
28246142

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP